Prior authorization denials land on pharmacists constantly, even though pharmacists rarely control the appeal itself. A patient shows up expecting to fill a prescription, the claim rejects with a PA requirement, and the pharmacist becomes the point of contact for a process that’s largely happening between the prescriber’s office and the payer. Understanding where the pharmacist’s role starts and stops — and where it can expand — helps set realistic expectations for patients and staff.
For background on pharmacist involvement in prior authorization generally, see our overview of the pharmacist’s role in prior authorization. This post focuses specifically on what happens after a PA is denied and an appeal begins.
Who actually files the appeal
In most cases, the formal PA appeal is filed by the prescriber’s office, not the pharmacy. The appeal typically requires clinical justification — why the requested medication is necessary over formulary alternatives, relevant diagnosis codes, prior treatment failures, and supporting clinical documentation. That information sits with the prescriber, not the dispensing pharmacy.
The pharmacist’s role is usually more indirect but still significant:
Identifying the denial reason. Rejection codes at the pharmacy counter often don’t explain much. Pharmacists frequently have to interpret payer rejection messages, determine whether it’s a hard PA requirement versus a step therapy or quantity limit issue, and communicate that clearly to the prescriber’s office so the right kind of appeal gets filed.
Flagging urgency. For medications where a delay creates clinical risk, pharmacists are often positioned to identify and escalate the urgency to the prescriber — since they’re the ones who see the gap in therapy in real time.
Supporting documentation from the pharmacy side. In some cases, pharmacies provide claims history, prior fill records, or formulary alternative information that supports the prescriber’s appeal, even though the pharmacist doesn’t submit the clinical appeal directly.
Advising on interim options. While an appeal is pending, pharmacists often help identify short-term alternatives — a covered formulary substitute, an emergency supply provision, or a manufacturer assistance program — to bridge the gap.
The appeal process, generally
Most PA appeals follow a similar general structure, though the specific steps and terminology differ by payer:
- Initial denial at the point of the claim, with a stated reason code.
- Internal (first-level) appeal, filed by the prescriber, reviewed by the payer’s own clinical staff.
- Payer determination — approval, or the denial is upheld.
- External review, if the internal appeal is denied — an independent review, often required by state law for certain plan types, with its own timeline and process.
Timelines vary by state and plan type
Turnaround requirements for PA decisions and appeals are frequently governed by state insurance law for state-regulated plans, though self-funded employer plans (governed by ERISA) often follow federal rather than state timelines — a distinction that matters when pharmacy staff are advising patients on what to expect. Standard versus expedited/urgent review timelines also typically differ significantly, with urgent reviews required to move faster given the clinical stakes. Because these timelines vary by state and plan type, it’s worth confirming the applicable timeframe rather than assuming a single standard applies everywhere.
Where pharmacists can add the most value
The most useful thing a pharmacy can do in this process is usually not filing the appeal itself, but reducing friction: clearly communicating the specific denial reason to the prescriber’s office (rather than a vague “it needs a PA”), flagging clinical urgency when relevant, and helping the patient understand realistic timelines so they’re not caught off guard. Pharmacies that build a consistent internal workflow for this — a standard way of documenting and routing PA denials — tend to see fewer dropped therapies and fewer angry phone calls.
This process intersects with broader payer relationship issues as well; our piece on pharmacy third-party payer contract basics covers how PA requirements get built into payer contracts in the first place.
A note on scope
None of this is legal or clinical advice for a specific denial or appeal. PA and appeal rules vary by state, by payer, and by plan type, and they change. If you’re navigating a specific denial, confirm the applicable timelines and requirements with the payer directly, and consult your state insurance department or a healthcare attorney for anything involving a disputed denial with real clinical stakes.
RxByState tracks regulatory changes affecting pharmacy practice, including state rules that shape PA and appeal timelines. Start a free 14-day trial →